Gluten in Medicine Disclosure Act of 2015

Bill: 114-hr-3648
Sponsor: full_name: Rep. Ryan, Tim [D-OH-13]
Introduced: 2015-09-29
Policy area: Health
Subjects: Consumer affairs

Drug safety, medical device, and laboratory regulation

Grain

Nutrition and diet

Prescription drugs
Latest action: action_date: 2015-10-02
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2015-09-29
action_desc: Introduced in House
text: <p><b>Gluten in Medicine Disclosure Act of 2015</b></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of any drug intended for human use that contains an ingredient other than a polyol that constitutes or is derived from a grain or starch-containing ingredient and whose label does not include a parenthetical statement identifying the source of that ingredient.</p>

tv_txt: I 114th CONGRESS 1st Session H. R. 3648 IN THE HOUSE OF REPRESENTATIVES September 29, 2015 Mr. Ryan of Ohio (for himself and Mrs. Lowey ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to require the label of drugs intended for human use to contain a parenthetical statement identifying the source of any ingredient constituting or derived from a grain or starch-containing ingredient.

1. Short title This Act may be cited as the Gluten in Medicine Disclosure Act of 2015 . 2. Labeling of source of human drug ingredients constituting or derived from a grain or starch-containing ingredient (a) Misbranding Section 502 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352 ) is amended by adding at the end the following: (dd) If it is a drug— (1) that is intended for human use; (2) that contains an ingredient (other than a polyol) that constitutes or is derived from a grain or starch-containing ingredient; and (3) whose label fails to include a parenthetical statement identifying the source of the ingredient so constituted or derived. . (b) Applicability Section 502(dd) of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a) of this section, shall apply beginning on the sooner of— (1) a date to be determined by the Secretary of Health and Human Services; and (2) the date that is 2 years after the date of the enactment of this Act.